Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 134

1.

Clozapine improves deficient inhibitory auditory processing in DBA/2 mice, via a nicotinic cholinergic mechanism.

Simosky JK, Stevens KE, Adler LE, Freedman R.

Psychopharmacology (Berl). 2003 Feb;165(4):386-96. Epub 2002 Nov 30.

PMID:
12459928
2.

Olanzapine improves deficient sensory inhibition in DBA/2 mice.

Simosky JK, Freedman R, Stevens KE.

Brain Res. 2008 Oct 3;1233:129-36. doi: 10.1016/j.brainres.2008.07.057. Epub 2008 Jul 25.

3.

Tropisetron improves deficient inhibitory auditory processing in DBA/2 mice: role of alpha 7 nicotinic acetylcholine receptors.

Hashimoto K, Iyo M, Freedman R, Stevens KE.

Psychopharmacology (Berl). 2005 Nov;183(1):13-9. Epub 2005 Oct 22.

PMID:
16136299
4.

Intragastric DMXB-A, an alpha7 nicotinic agonist, improves deficient sensory inhibition in DBA/2 mice.

Simosky JK, Stevens KE, Kem WR, Freedman R.

Biol Psychiatry. 2001 Oct 1;50(7):493-500.

PMID:
11600102
5.

Stimulation of the alpha4beta2 nicotinic receptor by 5-I A-85380 improves auditory gating in DBA/2 mice.

Wildeboer KM, Stevens KE.

Brain Res. 2008 Aug 11;1224:29-36. doi: 10.1016/j.brainres.2008.06.007. Epub 2008 Jun 11.

6.

Alpha4beta2 nicotinic receptor stimulation contributes to the effects of nicotine in the DBA/2 mouse model of sensory gating.

Radek RJ, Miner HM, Bratcher NA, Decker MW, Gopalakrishnan M, Bitner RS.

Psychopharmacology (Berl). 2006 Jul;187(1):47-55. Epub 2006 May 6.

PMID:
16767415
7.

Acute administration of Δ⁹ tetrahydrocannabinol does not prevent enhancement of sensory gating by clozapine in DBA/2 mice.

Smucny J, Stevens KE, Tregellas JR.

Pharmacol Biochem Behav. 2014 Mar;118:22-9. doi: 10.1016/j.pbb.2014.01.001. Epub 2014 Jan 10.

8.

Ondansetron results in improved auditory gating in DBA/2 mice through a cholinergic mechanism.

Wildeboer KM, Zheng L, Choo KS, Stevens KE.

Brain Res. 2009 Dec 1;1300:41-50. doi: 10.1016/j.brainres.2009.08.075. Epub 2009 Sep 1.

9.

The smoking cessation drug varenicline improves deficient P20-N40 inhibition in DBA/2 mice.

Wildeboer-Andrud KM, Stevens KE.

Pharmacol Biochem Behav. 2011 Nov;100(1):17-24. doi: 10.1016/j.pbb.2011.07.001. Epub 2011 Jul 7.

10.

Effects of the novel α7 nicotinic acetylcholine receptor agonist ABT-107 on sensory gating in DBA/2 mice: pharmacodynamic characterization.

Radek RJ, Robb HM, Stevens KE, Gopalakrishnan M, Bitner RS.

J Pharmacol Exp Ther. 2012 Dec;343(3):736-45. doi: 10.1124/jpet.112.197970. Epub 2012 Sep 17.

11.

Monoamine reuptake inhibition and nicotine receptor antagonism reduce amplitude and gating of auditory evoked potentials.

Siegel SJ, Maxwell CR, Majumdar S, Trief DF, Lerman C, Gur RE, Kanes SJ, Liang Y.

Neuroscience. 2005;133(3):729-38.

PMID:
15908134
12.

Permanent improvement in deficient sensory inhibition in DBA/2 mice with increased perinatal choline.

Stevens KE, Adams CE, Yonchek J, Hickel C, Danielson J, Kisley MA.

Psychopharmacology (Berl). 2008 Jun;198(3):413-20. doi: 10.1007/s00213-008-1170-3. Epub 2008 Apr 30.

PMID:
18446322
13.

Alpha-7 nicotinic receptor agonists: potential new candidates for the treatment of schizophrenia.

Martin LF, Kem WR, Freedman R.

Psychopharmacology (Berl). 2004 Jun;174(1):54-64. Epub 2004 Feb 19. Review.

PMID:
15205879
14.

Role of beta2-containing nicotinic acetylcholine receptors in auditory event-related potentials.

Rudnick ND, Koehler C, Picciotto MR, Siegel SJ.

Psychopharmacology (Berl). 2009 Mar;202(4):745-51. doi: 10.1007/s00213-008-1358-6. Epub 2008 Oct 18.

PMID:
18931833
15.

Intermittent versus continuous central administration of clozapine in DBA/2 mice, improvement in sensory inhibition deficits.

Stevens KE, Zheng L, Abrams DJ.

Schizophr Res. 2013 Sep;149(1-3):121-6. doi: 10.1016/j.schres.2013.06.007. Epub 2013 Jul 15.

PMID:
23863771
17.

Nicotine receptor subtype-specific effects on auditory evoked oscillations and potentials.

Featherstone RE, Phillips JM, Thieu T, Ehrlichman RS, Halene TB, Leiser SC, Christian E, Johnson E, Lerman C, Siegel SJ.

PLoS One. 2012;7(7):e39775. doi: 10.1371/journal.pone.0039775. Epub 2012 Jul 20.

18.

Nicotinic agonists and psychosis.

Simosky JK, Stevens KE, Freedman R.

Curr Drug Targets CNS Neurol Disord. 2002 Apr;1(2):149-62. Review.

PMID:
12769624
19.

The selective nicotinic acetylcholine receptor alpha7 agonist JN403 is active in animal models of cognition, sensory gating, epilepsy and pain.

Feuerbach D, Lingenhoehl K, Olpe HR, Vassout A, Gentsch C, Chaperon F, Nozulak J, Enz A, Bilbe G, McAllister K, Hoyer D.

Neuropharmacology. 2009 Jan;56(1):254-63. doi: 10.1016/j.neuropharm.2008.08.025. Epub 2008 Aug 28.

PMID:
18793655
20.

Selective alpha7-nicotinic agonists normalize inhibition of auditory response in DBA mice.

Stevens KE, Kem WR, Mahnir VM, Freedman R.

Psychopharmacology (Berl). 1998 Apr;136(4):320-7.

PMID:
9600576
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk